Heparin Gilvasan 5000 IE/ml – Injektions-/Infusionslösung clinical trials

An investigation of clinical outcomes and inflammatory response to heparin free extracorporeal membrane oxygenation support during clinical lung transplantation – a prospective double-blind randomised feasibility study. “Zero-Hep”

This study, called "Zero-Hep," is looking into how well a new way of doing lung transplants works. It's focused on a special type of life support called ECMO, but without using a blood-thinning medicine called heparin. Researchers want to see if this method causes fewer blood clots and other problems.